Israel sees drop in Pfizer vaccine protection against infections

Published July 6, 2021
An Israeli girl receives a dose of the Pfizer/BioNTech Covid-19 vaccine during a campaign by the Tel Aviv-Yafo Municipality to encourage the vaccination of teenagers, on July 5. — AFP
An Israeli girl receives a dose of the Pfizer/BioNTech Covid-19 vaccine during a campaign by the Tel Aviv-Yafo Municipality to encourage the vaccination of teenagers, on July 5. — AFP

Israel reported on Monday a decrease in the effectiveness of the Pfizer/BioNTech Covid-19 vaccine in preventing infections and symptomatic illness but said it remained highly effective in preventing serious illness.

The decline coincided with the spread of the Delta variant and the end of social distancing restrictions in Israel.

Vaccine effectiveness in preventing both infection and symptomatic disease fell to 64 per cent since June 6, the health ministry said.

At the same time the vaccine was 93pc effective in preventing hospitalisations and serious illness from the coronavirus.

Read: Thai leaked memo says Pfizer booster shot might dent confidence in Sinovac

The ministry in its statement did not say what the previous level was or provide any further details. However ministry officials published a report in May that two doses of Pfizer's vaccine provided more than 95pc protection against infection, hospitalisation and severe illness.

A Pfizer spokesperson declined to comment on the data from Israel, but cited other research showing that antibodies elicited by the vaccine were still able to neutralise all tested variants, including Delta, albeit at reduced strength.

About 60pc of Israel's 9.3 million population have received at least one shot of Pfizer's vaccine in a campaign that saw daily cases drop from more than 10,000 in January to single digits last month.

This spurred Israel to drop nearly all social distancing as well as the requirement to wear masks, though the latter was partially reimposed in recent days. At the same time Delta, which has become a globally dominant variant of the coronavirus, began to spread.

Since then daily cases have gradually risen, reaching 343 on Sunday. The number of seriously ill rose to 35 from 21.

Data scientist Eran Segal of Israel's Weizmann Institute of Science said the country was unlikely to experience the high levels of hospitalisations seen earlier in the year since there were much fewer critically ill.

He said it was fine to “continue with life back to normal and without restrictions” while stepping up measures like vaccination outreach and ensuring testing for Israelis returning home from abroad.

Opinion

Who bears the cost?

Who bears the cost?

This small window of low inflation should compel a rethink of how the authorities and employers understand the average household’s

Editorial

Internet restrictions
Updated 23 Dec, 2024

Internet restrictions

Notion that Pakistan enjoys unprecedented freedom of expression difficult to reconcile with the reality of restrictions.
Bangladesh reset
23 Dec, 2024

Bangladesh reset

THE vibes were positive during Prime Minister Shehbaz Sharif’s recent meeting with Bangladesh interim leader Dr...
Leaving home
23 Dec, 2024

Leaving home

FROM asylum seekers to economic migrants, the continuing exodus from Pakistan shows mass disillusionment with the...
Military convictions
Updated 22 Dec, 2024

Military convictions

Pakistan’s democracy, still finding its feet, cannot afford such compromises on core democratic values.
Need for talks
22 Dec, 2024

Need for talks

FOR a long time now, the country has been in the grip of relentless political uncertainty, featuring the...
Vulnerable vaccinators
22 Dec, 2024

Vulnerable vaccinators

THE campaign to eradicate polio from Pakistan cannot succeed unless the safety of vaccinators and security personnel...